116 related articles for article (PubMed ID: 38301858)
1. FBXO8 is a novel prognostic biomarker in different molecular subtypes of breast cancer and suppresses breast cancer progression by targeting c-MYC.
Khan AJ; Man S; Abbas M; Liu S; Zhang F
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130577. PubMed ID: 38301858
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
3. Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer.
Ali A; Shafarin J; Unnikannan H; Al-Jabi N; Jabal RA; Bajbouj K; Muhammad JS; Hamad M
Int J Biol Sci; 2021; 17(15):4474-4492. PubMed ID: 34803511
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.
Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818
[TBL] [Abstract][Full Text] [Related]
5. [Knockdown of IGF2BP2 inhibits colorectal cancer cell proliferation, migration and promotes tumor immunity by down-regulating MYC expression].
Liu T; Han C; Hu C; Mao S; Sun Y; Yang S; Yang K
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Apr; 39(4):303-310. PubMed ID: 37087547
[TBL] [Abstract][Full Text] [Related]
6. SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers.
Usman M; Hameed Y; Ahmad M; Iqbal MJ; Maryam A; Mazhar A; Naz S; Tanveer R; Saeed H; Bint-E-Fatima ; Ashraf A; Hadi A; Hameed Z; Tariq E; Aslam AS
Curr Mol Med; 2023; 23(2):161-176. PubMed ID: 35023455
[TBL] [Abstract][Full Text] [Related]
7. MYC dysfunction modulates stemness and tumorigenesis in breast cancer.
Liu Y; Zhu C; Tang L; Chen Q; Guan N; Xu K; Guan X
Int J Biol Sci; 2021; 17(1):178-187. PubMed ID: 33390842
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients.
Ibusuki M; Yamamoto Y; Shinriki S; Ando Y; Iwase H
Cancer Sci; 2011 Feb; 102(2):439-45. PubMed ID: 21134077
[TBL] [Abstract][Full Text] [Related]
9. FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma.
Wang F; Qiao Y; Yu J; Ren X; Wang J; Ding Y; Zhang X; Ma W; Ding Y; Liang L
PLoS One; 2013; 8(6):e65495. PubMed ID: 23826080
[TBL] [Abstract][Full Text] [Related]
10. FBXW7 circular RNA regulates proliferation, migration and invasion of colorectal carcinoma through NEK2, mTOR, and PTEN signaling pathways in vitro and in vivo.
Lu H; Yao B; Wen X; Jia B
BMC Cancer; 2019 Sep; 19(1):918. PubMed ID: 31519156
[TBL] [Abstract][Full Text] [Related]
11. FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma.
Li Z; Xiao J; Hu K; Wang G; Li M; Zhang J; Cheng G
Int J Mol Sci; 2015 Jan; 16(2):2294-306. PubMed ID: 25622249
[TBL] [Abstract][Full Text] [Related]
12. The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cells.
AlSultan D; Kavanagh E; O'Grady S; Eustace AJ; Castell A; Larsson LG; Crown J; Madden SF; Duffy MJ
Invest New Drugs; 2021 Apr; 39(2):587-594. PubMed ID: 33052557
[TBL] [Abstract][Full Text] [Related]
13. PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop.
Zhao X; Shu D; Sun W; Si S; Ran W; Guo B; Cui L
Cancer Commun (Lond); 2022 Oct; 42(10):987-1007. PubMed ID: 36002342
[TBL] [Abstract][Full Text] [Related]
14. Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer.
Lorentzen A; Lewinsky RH; Bornholdt J; Vogel LK; Mitchelmore C
BMC Cancer; 2011 Jan; 11():14. PubMed ID: 21226903
[TBL] [Abstract][Full Text] [Related]
15. The role of c-Myc-RBM38 loop in the growth suppression in breast cancer.
Li XX; Shi L; Zhou XJ; Wu J; Xia TS; Zhou WB; Sun X; Zhu L; Wei JF; Ding Q
J Exp Clin Cancer Res; 2017 Apr; 36(1):49. PubMed ID: 28399911
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA FGF13-AS1 inhibits glycolysis and stemness properties of breast cancer cells through FGF13-AS1/IGF2BPs/Myc feedback loop.
Ma F; Liu X; Zhou S; Li W; Liu C; Chadwick M; Qian C
Cancer Lett; 2019 May; 450():63-75. PubMed ID: 30771425
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
18. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
Li M; Li A; Zhou S; Lv H; Yang W
J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
[TBL] [Abstract][Full Text] [Related]
19. C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.
Balamurugan K; Mendoza-Villanueva D; Sharan S; Summers GH; Dobrolecki LE; Lewis MT; Sterneck E
Oncogene; 2019 May; 38(20):3765-3780. PubMed ID: 30262865
[TBL] [Abstract][Full Text] [Related]
20. METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression.
Xia P; Zhang H; Lu H; Xu K; Jiang X; Jiang Y; Gongye X; Chen Z; Liu J; Chen X; Ma W; Zhang Z; Yuan Y
Cancer Commun (Lond); 2023 Mar; 43(3):338-364. PubMed ID: 36602428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]